17 September 2021
Anna Kuznetsova, the Presidential Commissioner for Children’s Rights, suggested improvements for the procedure for purchasing medicines for children with cancer, which would create an opportunity to announce a competitive tender for a specific trade name. This was reported by RIA Novosti.
Kuznetsova took part in a round table discussion on the provision of medicines for children with cancer held at the United Russia site.
“It is proposed to develop a special procedure for the procurement of medicines, which provides for the possibility of declaring a tender for a trade name. In our opinion, to do that, it is necessary to supplement the list of grounds for the corresponding decision of the medical commission, except for individual intolerance or vital indications,” the ombudswoman said during the event.
It is also proposed to provide doctors with the necessary information about possible side effects of the drug or its insufficient effectiveness.
Secondly, as Anna Kuznetsova stressed, we need to develop measures to improve the mechanism for transmitting information from parents to Roszdravnadzor, registration of side effects of drugs, including by simplifying the procedures related to the establishment of unfavourable events.
The Ombudswoman previously proposed to introduce certificates for the purchase of medicines for seriously ill children.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024